Disclosures for "Effects of APOE Genotypes on Periventricular White Matter Cerebral Blood Flow in Cognitively Intact Adults"
-
Dr. Sadaghiani has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Dolui has nothing to disclose.
-
Dr. Shakibajahromi has nothing to disclose.
-
Dr. Das has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nia Therapeutics. The institution of Dr. Das has received research support from NIH.
-
Author has nothing to disclose
-
Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Eli Lilly.
-
Dr. Detre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hura Imaging. The institution of Dr. Detre has received research support from NIH. Dr. Detre has received personal compensation in the range of $500-$4,999 for serving as a grant proposal reviewer with NIH, VA, European Science Foundation,Deutsche Forschungsgemeinschaft.